Nurix Therapeutics Inc (NRIX)

R&D to Revenue

11.78%

Quarterly · Period ending:

NRIX logo

NRIX R&D to Revenue

Latest reported11.78%
NRIX Quarterly R&D/Revenue (113.00% → 11.78%)
High-resolution chart · PNG

NRIX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
11.776%
969.2912%
1,345.7614%
595.8901%
1,090.9552%
177.2653%
377.5159%
506.0524%
440.7452%
404.5815%
301.5074%
327.9438%
259.1433%
149.1818%
361.1825%
679.7287%
442.6003%
415.4391%
448.363%
493.9292%
301.4631%
366.5774%
459.0501%
305.6511%
463.623%
338.1636%
452.7584%
688.7218%
104.0454%
113.9845%
112.9955%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.